Lisa Mostovoy, PharmD, MBA

home / authors / lisa-mostovoy-pharmd-mba

Articles

Conventional and Biologic Rheumatoid Arthritis Therapies: Utilization and Cost Trends

Osayi Akinbosoye, PhD, PAHM;Olga S. Matlin, PhD;Lisa Mostovoy, PharmD, MBA;Frederick Brown, PharmD;John A. Szychowski, AAS, BS

December 12th 2012

Based on American College of Rheumatology recommendations and novel emerging treatment options, the trend of increasing biologic use for rheumatoid arthritis is expected to continue.

Trends in First-Year Utilization Costs of HIV Medications

Anthony Palmieri, RPh, PharmD, MBA;Lisa Mostovoy, PharmD, MBA;Osayi Akinbosoye, PhD, PAHM;John A. Szychowski, AAS, BS;Marina L. Sehman, RPh, PharmD;Olga S. Matlin, PhD

October 17th 2012

HIV is of interest among many in managed care. This paper focuses on the costs and demographic characteristics associated with new HIV therapy initiators.

Published: October 23rd 2024 | Updated: October 24th 2024

What to Know About E Coli Outbreak Linked to McDonald’s Quarter Pounders